Explore UAB

  • Announcing research leadership changes in the Heersink School of Medicine
    Orlando Gutiérrez, M.D., will be appointed senior associate dean for Clinical and Translational Research in the UAB Marnix E. Heersink School of Medicine and director and contact principal investigator of the UAB Center for Clinical and Translational Science. In this role, Gutiérrez will also serve as the associate vice president of Medicine and Biomedical Research for UAB. In turn, Robert Kimberly, M.D., will transition into the newly created role of senior associate dean for Strategic Initiatives in the Heersink School of Medicine. Both appointments are effective April 1, 2024.
  • Three research projects awarded funding from the Immunology Institute Pilot Project program
    The program seeks to support and foster multidisciplinary collaborations, especially between UAB clinicians and basic and physician scientists.
  • Rheumatologists launch free phone-based app for patients with lupus
    The MyLupus app is a patient-friendly, patient-focused decision-aid tool for people from all backgrounds with moderate to severe lupus.
  • Flu: Interferon-gamma from T follicular helper cells is required to create lung-resident memory B cells
    Lung-resident memory B cells produced during influenza are long-living immune cells that migrate to the lungs from draining lymph nodes and lie in wait as early responders that can quickly react to future infections. They are key sentinels against subsequent viral variants.
  • Osteoporosis: UAB-led study approved for a $13.9 million award to investigate prevention of bone fractures
    The study, funded by the Patient-Centered Outcomes Research Institute, will compare two pathways of post-fracture patient care.
  • $6.9 million awarded to UAB to continue knee osteoarthritis research
    $46 million awarded by NIH to UAB and partners allows researchers to continue following participants enrolled in the national Multicenter Osteoarthritis Study.
  • How interleukin-6 helps prevent allergic asthma and atopy by suppressing interleukin-2 signaling
    Knowledge of this previously unrecognized mechanism may aid therapy for patients with interleukin-6 signaling mutations and hyper-IgE Syndrome, or HIES.
  • How cadmium-induced inflammation increases the severity and mortality of lung infections
    Description of this mechanism offers a promising therapeutic target to limit lung injury and death. Lower respiratory tract infections, including bacterial pneumonia, are the fourth-leading cause of death worldwide, with 120 million to 156 million cases and 1.4 million deaths a year.
  • Memory B cell marker predicts long-lived antibody response to flu vaccine
    These effector memory B cells appear poised for a rapid serum antibody response upon secondary challenge one year later, and evidence shows that the cells in this subset differ from all previously described memory B cell subsets.
  • UAB patient shares difficult experience to warn others of the dangers of scleroderma
    One UAB patient uses her transformational story to spread awareness of scleroderma.
  • With eight highly ranked specialties, U.S. News again calls UAB best hospital in Alabama
    U.S. News & World report named UAB Hospital as the best hospital in Alabama.
  • UAB rheumatology care expands to Hoover clinic
    UAB rheumatologists will begin seeing patients at the UAB Hoover Primary Care clinic in July 2022.